Drug resistance mutations in proviral DNA of HIV-infected patients with low level of viremia
Drug resistance mutations in proviral DNA of HIV-infected patients with low level of viremia J …

Background. Technical limitations in the sensitivity of commercial genotyping methods may
prevent clinicians from determining whether drug-resistant human immunodeficiency virus …

Objectives Transmitted HIV strains may harbour drug resistance mutations. HIV‐1 drug
resistance mutations are currently detected in plasma viral RNA. HIV‐1 proviral DNA could …

Objective To study the appearance of drug-induced mutations at low viraemia in treated HIV-
1-infected patients. Design and methods Fourteen patients, who received their first (n= 5) …

The frequency of protease and reverse transcriptase (RT) gene mutations was determined in
HIV-1 strains from 153 patients entering the CPCRA 046 (GART) study who were failing …

In 32 patients for whom highly active antiretroviral therapy was failing, a good agreement
between drug resistance-associated mutations in plasma and peripheral blood …

BACKGROUND: HIV drug resistance (HDR) represents a crucial problem in antiretroviral
therapy today. HDR mutations can accumulate, persist in the proviral genome and re …

Point mutations in the reverse transcriptase (RT) gene of human immunodeficiency virus
type-1 (HIV-1) have been associated with reduced sensitivity of the virus to inhibition by the …

This study characterized the prevalence and patterns of antiretroviral-drug-resistance
mutations according to plasma human immunodeficiency virus type 1 (HIV-1) RNA load in a …

BACKGROUND: Since HIV infection cannot be completely eliminated due to the
establishment of latently infected CD4+ T cell reservoirs, there is an urgent need for a …